Expression of the anti-inflammatory, antioxidative phase II detoxifying enzyme heme oxygenase-1 (HO-1) is decreased in the brain prefrontal cortex of HIV+ individuals in association with increased neuroinflammation and neurocognitive impairment. In vitro HIV infection of monocyte-derived macrophages (MDM) induces HO-1 deficiency and increases release of neurotoxic levels of glutamate. We recently showed that HO-1 deficiency is consistently seen with HIV MDM infection by a broad panel of macrophage-tropic clade B HIV-1 strains (n=13). This suggests that induction of HO-1 deficiency is a highly conserved macrophage-tropic HIV phenotype that could be particularly relevant for neuropathogenesis driven by infection within the CNS myeloid reservoir.
Human MDM (n=4 donors) were infected with viruses derived from infectious molecular clones of each of 5 clade D transmitted/founder (T/F) strains or the clade B 89.6 strain. Viral replication, glutamate concentration, and neurotoxicity of MDM culture supernatants were determined via reverse transcriptase (RT) activity, glutamate assay, and neuron-based MAP2 ELISA, respectively. Data were analyzed by ANOVA with Holm-Sidak post hoc test or Pearson’s correlation.
In contrast with MDM infection by 89.6, infection by macrophage-tropic clade D T/F viruses did not significantly decrease HO-1 expression or increase glutamate release, despite similar replication levels as 89.6. Unexpectedly, infection by clade D T/F viruses significantly increased MDM culture supernatant neurotoxicity despite no induction of glutamate release (n=4 donors, p<0.001 for equivalent replication to 89.6). This suggests that macrophage-tropic clade D T/F viruses can activate pathways of neurotoxin production independent of HO-1 and associated effects on glutamate metabolism.
Our results suggest that macrophage-tropic clade D T/F viruses differ from clade B viruses in several potentially critical determinants of neurovirulence; differential ability to i) reduce expression of MDM HO-1 expression and to ii) induce glutamate release from MDM. Nonetheless, macrophage-tropic clade D T/F viruses can induce release of neurotoxins other than glutamate (as yet unidentified) from MDM without altering HO-1 expression, and this suggests potential clade- or T/F virus-specific mechanisms of HIV neurotoxin production. Such differences could contribute to variance in severity of neurological dysfunction among populations infected with different HIV clades.